NCI’s myeloMATCH will use biomarkers to match patients with myeloid cancer to trials

Ned Sharpless’s portrait unveiled at FNIH ceremony

Former NCI director Norman “Ned” Sharpless had his portrait unveiled at a ceremony hosted by the Foundation for the National Institutes of Health on the main NIH campus in Bethesda.

July 10, 2026

Vol.52 No.27

Clinical Roundup

NYU Langone study sheds light on early respiratory failure in AML

A study led by researchers at NYU Langone Health shows how blood cancer cells enter the lungs, damage tissue, and cause severe breathing problems.

July 02, 2026

Vol.52 No.26

Podcast The Directors

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”

How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.

June 26, 2026

Vol.52 No.25

By Paul Goldberg and Claire Marie Porter

In Brief

NCI renews the UC San Diego Moores CCSG, committing $25M

University of California San Diego Moores Cancer Center has received a five-year, $25 million Cancer Center Support Grant from NCI.

June 18, 2026

Vol.52 No.24

Capitol Hill

House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget

On June 9, the House Appropriations Committee passed its version of the fiscal year 2027 spending bill for Labor, Health and Human Services, and Education.

June 12, 2026

Vol.52 No.23

By Paul Goldberg

As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded

Last week, Wafik El-Deiry, a cancer researcher at Brown University, showed up at a Senate hearing to talk about what he sees as dangers of the COVID-19 vaccine.

June 12, 2026

Vol.52 No.23

By Paul Goldberg

NCI’s myeloMATCH will use biomarkers to match patients with myeloid cancer to trials

YOU MAY BE INTERESTED IN

Ned Sharpless’s portrait unveiled at FNIH ceremony

NYU Langone study sheds light on early respiratory failure in AML

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”

NCI renews the UC San Diego Moores CCSG, committing $25M

House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget

As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded

Renew today!

Subscriber content

Never miss an issue!

Login

NCI’s myeloMATCH will use biomarkers to match patients with myeloid cancer to trials

YOU MAY BE INTERESTED IN

Ned Sharpless’s portrait unveiled at FNIH ceremony

NYU Langone study sheds light on early respiratory failure in AML

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas“Institutions are feeling crunched in so many different directions”

NCI renews the UC San Diego Moores CCSG, committing $25M

House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget

As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick labThe job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded

Never miss an issue!

Login

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”

As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded